#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Human papilloma virus immunisation Congenital nephrogenic diabetes insipidus Hereditary ataxia Eosinophilic oesophagitis Epileptic encephalopathy Precursor T-lymphoblastic lymphoma/leukaemia recurrent Extraskeletal ossification Juvenile chronic myelomonocytic leukaemia Myeloproliferative neoplasm Infantile apnoea Chronic kidney disease Astrocytoma Hereditary haemorrhagic telangiectasia Aplastic anaemia Shprintzen-Goldberg syndrome More trials…

    Learn about Rare Diseases

    Sjogren’s syndrome – Treatment VEXAS syndrome – Life with Disease X-linked lymphoproliferative syndrome Glycogen storage disease type I Myelodysplastic syndrome with excess blasts – Treatment Gaucher’s disease type I – Basic Information Nephroblastoma – Basic Information Ewing’s sarcoma metastatic – Trials in Disease Toxic epidermal necrolysis – Treatment Atypical teratoid/rhabdoid tumour of CNS More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Pristinamycin Taldefgrobep Alfa TUB-030 Enmetazobactam Cefazolin Sodium RIKKUNSHITO Ondansetron Hydrochloride Xanomeline Tartrate Ciclosporin A Tilsotolimod Sodium Brimonidine Tartrate Obinutuzumab NALDEMEDINE Mifepristone Dronabinol ZIMISLECEL Cortisone Acetate Dexamethasone Acetate Patisiran Pentoxifylline More therapies…

    Learn about Your Condition

    Onychomycosis Cervix carcinoma Uveal melanoma Prader-Willi syndrome Perineal injury Staphylococcal bacteraemia Thrombolysis Cardiac failure Glomerulonephritis acute Ischaemic skin ulcer Peripheral artery thrombosis Herpes simplex meningitis High-grade B-cell lymphoma Noninfective chorioretinitis Testicular germ cell tumour More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study on the Effectiveness and Safety of Rituximab for Patients with Progressive Interstitial Lung Disease with Inflammation

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Interstitial lung disease
    Investigated Drugs:
    • Sodium Chloride Ph. Eur.
    • Rituximab
    France

  • Study on Azathioprine for Preventing Relapse in Patients with Myelin Oligodendrocyte Glycoprotein Antibody Disease (MOG-AD) After First Attack

    Recruiting

    3 1 1
    Investigated Drugs:
    • Hydrocortisone
    • Prednisolone
    • Azathioprine
    France

  • Continued Treatment Study for Patients with Blood Cancers Using Tafasitamab

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Haematological malignancy
    Investigated Drugs:
    • Tafasitamab
    Hungary Italy Spain

  • Long-Term Study on the Safety and Effects of RP-L102 Infusion for Patients with Fanconi Anemia Subtype A

    Recruiting

    1 1 1
    Investigated Diseases:
    • Congenital aplastic anaemia
    Investigated Drugs:
    • Autologous Cd34+Enriched Cells From Patients With Fanconi Anemia Subtype A Transduced Ex Vivo With Lentiviral Vector Carrying The Fanconi Anemia Complementation Group A Gene
    Spain

  • Study on Rituximab for Patients with Acute Myocardial Infarction

    Recruiting

    2 1 1
    Investigated Diseases:
    • Electrocardiogram ST segment elevation
    Investigated Drugs:
    • Rituximab
    • Sodium Chloride
    Czechia France Germany The Netherlands Spain

  • Study on the Effect and Safety of Flecainide and Metoprolol for Patients with Arrhythmic Mitral Valve Prolapse

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Mitral valve prolapse
    Investigated Drugs:
    • Metoprolol
    • Flecainide
    Norway
Previous Page
1 … 571 572 573 574 575 … 1,654
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!